Wolfgang Lilleby

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi request reprint Chemotherapy in metastatic renal cell cancer
    Wolfgang Lilleby
    Department of Medical Oncology and Radiotherapy, The Norwegian Radium University Hospital, Oslo, Norway
    World J Urol 23:175-9. 2005
  2. ncbi request reprint [Treatment of hormone-resistant prostate cancer]
    Wolfgang Lilleby
    Fagområde stråleterapi, Rikshospitalet Radiumhospitalet, Montebello, 0310 Oslo
    Tidsskr Nor Laegeforen 126:2798-801. 2006
  3. ncbi request reprint [Biology and treatment options during the development of prostate cancer]
    Wolfgang Lilleby
    Avdeling for medikamentell onkologi, og stråleterapi, Radiumhospitalet, 0310 Oslo
    Tidsskr Nor Laegeforen 125:571-4. 2005
  4. doi request reprint Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
    Arne Berg
    Norwegian Radium Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway
    Prostate 68:1607-14. 2008
  5. ncbi request reprint [High dose rate brachytherapy in prostate cancer in Norway]
    Nils Kristian Raabe
    Kreftklinikken, Fagområdet onkologi, Rikshospitalet, 0027 Oslo
    Tidsskr Nor Laegeforen 128:1275-8. 2008
  6. doi request reprint Fertility issues in patients with prostate cancer
    Eivind A Steinsvik
    The Norwegian Radium Hospital, Cancer Clinic, University of Oslo, Oslo, Norway
    BJU Int 102:793-5. 2008
  7. ncbi request reprint Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate
    Wolfgang Lilleby
    Acta Oncol 46:1195-7. 2007
  8. ncbi request reprint 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
    Arne Berg
    Faculty of Medicine, University of Oslo, Oslo, Norway
    Int J Radiat Oncol Biol Phys 69:1074-83. 2007
  9. ncbi request reprint Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
    Arne Berg
    Faculty of Medicine, University of Oslo, Norway
    Int J Cancer 120:1603-9. 2007
  10. ncbi request reprint Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53
    Assia V Bassarova
    Department of Pathology, Alexander University Hospital, Medical University, Sofia, Bulgaria
    Int J Surg Pathol 13:239-46. 2005

Collaborators

  • S D Fossa
  • Arne Berg
  • Jon Sudbø
  • Assia V Bassarova
  • Emina Torlakovic
  • Goran Torlakovic
  • Nils Kristian Raabe
  • Eivind A Steinsvik
  • Rajni Chibbar
  • Aasmund Berner
  • Alexander Fosså
  • Karsten Eilertsen
  • Lennart Aström
  • Gunnar Tafjord
  • Torbjørn Furre
  • Gustav Gaudernack

Detail Information

Publications17

  1. ncbi request reprint Chemotherapy in metastatic renal cell cancer
    Wolfgang Lilleby
    Department of Medical Oncology and Radiotherapy, The Norwegian Radium University Hospital, Oslo, Norway
    World J Urol 23:175-9. 2005
    ..There is a great need to develop effective systemic therapy for advanced MRCC and to evaluate the efficacy of new drugs in clinical trials...
  2. ncbi request reprint [Treatment of hormone-resistant prostate cancer]
    Wolfgang Lilleby
    Fagområde stråleterapi, Rikshospitalet Radiumhospitalet, Montebello, 0310 Oslo
    Tidsskr Nor Laegeforen 126:2798-801. 2006
    ..The survival of future patients with such cancer is expected to improve if multidisciplinary health care teams with knowledge of prostate cancer tumour biology administer new treatments...
  3. ncbi request reprint [Biology and treatment options during the development of prostate cancer]
    Wolfgang Lilleby
    Avdeling for medikamentell onkologi, og stråleterapi, Radiumhospitalet, 0310 Oslo
    Tidsskr Nor Laegeforen 125:571-4. 2005
    ..Compelling evidence indicates that environmental and life-style factors, in addition to well-known risk factors such as testosterone level and age, are important for the development of prostate cancer...
  4. doi request reprint Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
    Arne Berg
    Norwegian Radium Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway
    Prostate 68:1607-14. 2008
    ....
  5. ncbi request reprint [High dose rate brachytherapy in prostate cancer in Norway]
    Nils Kristian Raabe
    Kreftklinikken, Fagområdet onkologi, Rikshospitalet, 0027 Oslo
    Tidsskr Nor Laegeforen 128:1275-8. 2008
    ..This article presents a study of the first 100 patients in Norway with localized/locally advanced prostate cancer treated with high dose-rate brachytherapy combined with external radiotherapy...
  6. doi request reprint Fertility issues in patients with prostate cancer
    Eivind A Steinsvik
    The Norwegian Radium Hospital, Cancer Clinic, University of Oslo, Oslo, Norway
    BJU Int 102:793-5. 2008
    ..To describe fertility issues, only rarely discussed with patients with prostate cancer, although paternity after treatment might be an important component of quality of life for some, as exemplified by two of our patients...
  7. ncbi request reprint Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate
    Wolfgang Lilleby
    Acta Oncol 46:1195-7. 2007
  8. ncbi request reprint 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
    Arne Berg
    Faculty of Medicine, University of Oslo, Oslo, Norway
    Int J Radiat Oncol Biol Phys 69:1074-83. 2007
    ....
  9. ncbi request reprint Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
    Arne Berg
    Faculty of Medicine, University of Oslo, Norway
    Int J Cancer 120:1603-9. 2007
    ..In conclusion our study shows that presence of DTCs in BM at diagnosis was associated with the histological differentiation of the primary tumor and an increased risk of developing distant metastases after RT...
  10. ncbi request reprint Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53
    Assia V Bassarova
    Department of Pathology, Alexander University Hospital, Medical University, Sofia, Bulgaria
    Int J Surg Pathol 13:239-46. 2005
    ..However, in patients with atypical medullary carcinoma there was no expression of ER-alpha or amplification of Her-2...
  11. ncbi request reprint Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma
    Emina Torlakovic
    Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway
    Int J Cancer 117:381-6. 2005
    ..Although stromal AR was doubled after RT, the tumor and benign epithelium expression of AR seemed resistant to change by RT...
  12. ncbi request reprint Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomy
    Sophie D Fossa
    Department of Clinical Research, The Norwegian Radium Hospital, Oslo, Norway
    Int J Radiat Oncol Biol Phys 57:33-41. 2003
    ..To evaluate the postradiotherapy 5-year cancer-specific (CSS), clinical progression-free (cPFS), and overall (OS) survival rates in patients with pN0 M0 prostate cancer (PC)...
  13. ncbi request reprint Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose
    Wolfgang Lilleby
    Department of Medical Oncology Radiotherapy, Norwegian Radium Hospital, Oslo, Norway
    Acta Oncol 42:10-4. 2003
    ..However, the mean beneficial sparing of rectal volume was outweighed in some patients by considerable inter-patient variations...
  14. ncbi request reprint The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
    Wolfgang Lilleby
    Department of Oncology Radiotherapy, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo, Norway
    Int J Cancer 103:91-6. 2003
    ..Although this association was not retained in multivariate analysis, our observations indicate that the presence of CK+ cells after local therapy define a group of patients that have a high risk of developing distant metastases...
  15. ncbi request reprint Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score
    Emina Torlakovic
    Department of Pathology, Norwegian Radium Hospital, Oslo, Norway
    Hum Pathol 33:646-51. 2002
    ..Our findings suggest that ER-beta, as detected by PPG5/10 antibody, may have a role in the process of dedifferentiation of prostate adenocarcinomas, with higher levels present in less differentiated tumors...
  16. ncbi request reprint Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
    Alexander Fosså
    Department of Immunology, The Norwegian Radium Hospital, Oslo, Norway
    Int J Cancer 99:100-5. 2002
    ....